These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

994 related articles for article (PubMed ID: 29029855)

  • 1. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
    McCullough M; Burg M; Lin E; Peng D; Garner W
    Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of Biobrane
    Rogers AD; Blackport E; Cartotto R
    Burns; 2017 Nov; 43(7):1464-1472. PubMed ID: 28526303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
    Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
    Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of porcine xenografts in patients with toxic epidermal necrolysis.
    Young JB; Gondek SP; Troche M; Summitt JB; Rae L; Thayer WP; Kahn SA
    Burns; 2016 Dec; 42(8):1728-1733. PubMed ID: 27350163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
    Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
    Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 10-year experience in a burns unit.
    Houschyar KS; Tapking C; Borrelli MR; Nietzschmann I; Puladi B; Ooms M; Rein S; Houschyar M; Duscher D; Maan ZN; Reumuth G; Branski LK; Modabber A; Kluwig D; Schmitt L; Philipp-Dormston WG; Yazdi AS; Siemers F
    J Wound Care; 2021 Jun; 30(6):492-496. PubMed ID: 34121430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Patients Treated With a Medicine-Led Multidisciplinary Approach.
    Lewcun JA; Vagonis A; Kontzias C; Newsom M; Drake M; Feldman MJ
    J Burn Care Res; 2024 Jan; 45(1):165-168. PubMed ID: 37698266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective review of 10-year experience.
    Zhang AJ; Nygaard RM; Endorf FW; Hylwa SA
    Int J Dermatol; 2019 Sep; 58(9):1069-1077. PubMed ID: 30825193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antishear Therapy for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Follow-up Study.
    Haravu PN; Gottlieb LJ; Vrouwe SQ
    J Burn Care Res; 2021 Nov; 42(6):1152-1161. PubMed ID: 34370855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 20-year single-center experience.
    Lalosevic J; Nikolic M; Gajic-Veljic M; Skiljevic D; Medenica L
    Int J Dermatol; 2015 Aug; 54(8):978-84. PubMed ID: 25385069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and costs of patients with toxic epidermal necrolysis: a 27-year retrospective study.
    Oen IM; van der Vlies CH; Roeleveld YW; Dokter J; Hop MJ; van Baar ME
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2444-50. PubMed ID: 26416341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nanocrystalline silver dressings in the management of toxic epidermal necrolysis (TEN) and TEN/Stevens-Johnson syndrome overlap.
    Smith SD; Dodds A; Dixit S; Cooper A
    Australas J Dermatol; 2015 Nov; 56(4):298-302. PubMed ID: 25368980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
    Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric toxic epidermal necrolysis: an institutional review of patients admitted to an intensive care unit.
    Hamilton GM; Fish J
    J Burn Care Res; 2013; 34(6):e351-8. PubMed ID: 23816996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining triage patterns of inhalation injury and toxic epidermal necrolysis-Stevens Johnson syndrome.
    Davis JS; Pandya RK; Pizano LR; Namias N; Dearwater S; Schulman CI
    J Burn Care Res; 2013; 34(5):492-7. PubMed ID: 23966120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
    Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
    Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and use of the auxiliary score in extensive toxic epidermal necrolysis patients admitted to an adult burns referral centre.
    Mahar PD; Wasiak J; Cleland H; Watters D; Paul E; Marsh P; Gin D
    Dermatology; 2013; 227(2):180-5. PubMed ID: 24080507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.